Milestone Pharmaceuticals said today that it closed a $55 million series C financing round. Led by Novo Holdings, the round also included new investors Forbion Capital Partners and Tekla Capital Management, as well as existing investors Domain Associates and Fonds de solidarité FTQ, BDC Capital, Pappas Capital, and GO Capital. The Montreal-based company is slated to use […]
milestonepharmaceutical
HRS 2017: First ever nasal spray used to treat rapid heart rate condition
Data from a 100-patient clinical trial showed that a fast-acting nasal spray therapy, etripamil, was effective at stopping a common rapid heart rate condition, researchers said today at the annual Heart Rhythm Society conference in Chicago. Paroxysmal supraventricular tachycardia is traditionally treated with adenosine, calcium channel blockers or beta blockers, which is administered using an IV […]